FDAFDA · Food and drugs·Recall number D-0493-2017
Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20
Published March 15, 2017 · Recall initiated: January 27, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- MIRTAZAPINE
- Manufacturer
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
- Distributor
- Nationwide
- Lot
- Batch #3083289; Exp. Date 12/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.